About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline
LOG IN
LOG IN

1 [1] (March 29, 2022)

handle is hein.crs/govegro0001 and id is 1 raw text is: Congress bnal Research Service inkurming th eg Ilaive debat sico 1.14 Updated March 29, 2022 Congressionally Directed Medical Research Programs Funding for FY2022 Members of Congress are frequently lobbied to add funding to annual defense appropriation legislation for certain medical research programs on a wide variety of diseases and topics. In addressing annual appropriations bills, many Members frequently seek information on enacted levels for such funding under the Congressionally Directed Medical Research Programs (CDMRP). CDMRP Administration and Funding The CDMRP is a Department of Defense (DOD) program that receives congressional appropriations explicitly for biomedical research in specific, congressionally identified health matters. As such, it is not part of the President's budget request for the DOD. The U.S. Army Medical Research and Development Command (USAMRDC) administers the CDMRP and is responsible for awarding and managing competitive grants. Congress usually inserts CDMRP funding as Undistributed Medical Research in the Defense Health Program's Research, Development, Test, and Evaluation (RDT&E) account in the annual DOD appropriation. Congressional documents accompanying the annual defense appropriation act (i.e., conference reports or explanatory statements) identify the specific research areas for a given fiscal year. The Consolidated Appropriations Act, 2022 (P.L. 117-103) inserted $1.518 billion into the RDT&E account for CDMRP. This amount comprises 58% of the overall Defense Health Program's RDT&E appropriation, as reflected in Figure 1. Biomedical research conducted by the Defense Advanced Research Projects Agency or other military research agencies is not included in this account. Figure 1. Total Defense Health Program RDT&E Appropriation, FY2022 (millions) Source: Explanatory Statement accompanying H.R. 2471, Congressional Record, March 9, 2022, p. H2155. Table 1 lists the FY2022 CDMRP funding amounts for specific medical research areas. Table I. CDMRP Funding, FY2022 (in millions of dollars) Program Title FY2022 Alcohol and Substance Use Disorders 4 Alzheimer's Disease 15 Amyotrophic Lateral Sclerosis 40 Autism I5 Bone Marrow Failure Disease 7.5 Breast Cancer 150 Chronic Pain Management 15 Combat Readiness Medical 10 Duchenne Muscular Dystrophy 10 Epilepsy 12 Global HIV/AIDS Prevention 10 Hearing Restoration 10 Joint Warfighter Medical 40 Kidney Cancer SO Lung Cancer 20 Lupus 10 Melanoma 40 Multiple Sclerosis 20 Orthotics and Prosthetics Outcomes 20 Ovarian Cancer 45 Pancreatic Cancer 15 Peer-Reviewed Cancer 130 Peer-Reviewed Medical 370 Peer-Reviewed Orthopedic 30 Prostate Cancer 110 Rare Cancers 17.5 Reconstructive Transplant 12 Spinal Cord Injury 40 Tick-Borne Disease 7 Toxic Exposures 30 Trauma Clinical 10 Traumatic Brain Injury and Psychological Health 175 Tuberous Sclerosis 8 Vision 20 TOTAL 1,518 Source: Explanatory Statement accompanying H.R. 2471, Congressional Record, March 9, 2022, p. H2155. 0

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Purchase Access

Already a HeinOnline Subscriber?

Log In

profiles profiles most